Qube Research & Technologies LTD Bristol Myers Squibb CO Call Options Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $18.6 Million - $24.2 Million	468,200 Added 150.5%	779,300 $40.3 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $7.71 Million - $10.1 Million	191,500 Added 160.12%	311,100 $12.9 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $14.8 Million - $16.7 Million	-307,700 Reduced 72.01%	119,600 $6.49 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $19.5 Million - $23.3 Million	403,000 Added 1658.44%	427,300 $21.9 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $1.41 Million - $1.57 Million	24,300 New	24,300 $1.41 Million
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $4.46 Million - $4.93 Million	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $4.51 Million - $5.38 Million	100,000 New	100,000 $4.77 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.